March 11, 2020 / 8:49 PM / 20 days ago

BRIEF-Arcturus Therapeutics Reports Fourth Quarter And Year End 2019 Financial Results

March 11 (Reuters) - Arcturus Therapeutics Holdings Inc :

* ARCTURUS THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS

* Q4 REVENUE $3.0 MILLION VERSUS REFINITIV IBES ESTIMATE OF $3.6 MILLION

* Q4 LOSS PER SHARE $0.76

* Q4 EARNINGS PER SHARE ESTIMATE $-0.53 — REFINITIV IBES DATA

* ARCTURUS THERAPEUTICS LTD - CORONAVIRUS VACCINE PROGRAM INITIATED

* ARCTURUS THERAPEUTICS LTD - IND FILED FOR FLAGSHIP PROGRAM ARCT-810

* ARCTURUS THERAPEUTICS LTD - CASH, CASH EQUIVALENTS, AND INVESTMENTS TOTALED $71.4 MILLION AS OF DECEMBER 31, 2019

* ARCTURUS THERAPEUTICS LTD - COMPANY’S CURRENT CASH POSITION IS EXPECTED TO BE SUFFICIENT TO SUPPORT OPERATIONS THROUGH Q1 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below